Clinical Trial Update: Efficacy Study of Paliperidone to Evaluate Subjective Change in Well-being and Drug Attitude in Schizophrenic Participants [Phase 4]

View source ↗

Summary

This document reports the results of a Phase 4 study evaluating Paliperidone's effect on subjective well-being and drug attitude in individuals with schizophren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• PALIPERIDONE (paliperidone)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2014-03-27